Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.

Area of Science:

• Immunology
• Autoimmunity
• Therapeutic Development

Background:

• Autoimmune diseases are characterized by autoantibody production from self-reactive plasma cells.
• Current therapies target B cell maturation or plasma cell depletion.
• Emerging evidence highlights the role of long-lived plasma cells in maintaining autoimmune memory and disease persistence.

Purpose of the Study:

• To re-evaluate the role of long-lived plasma cells in autoimmune diseases.
• To identify novel therapeutic targets beyond current B cell-centric strategies.
• To underscore the significance of persistent plasma cells in chronic autoimmunity.

Main Methods:

• Review of recent findings in B-cell biology and immunology.
• Analysis of the refractory nature of long-lived plasma cells to existing therapies.
• Evaluation of the contribution of these cells to humoral and autoreactive memory.

Main Results:

• Long-lived plasma cells are resistant to immunosuppressants and B cell depletion therapies.
• These cells contribute to the maintenance of humoral memory and autoreactive memory in autoimmunity.
• Persistent autoantibody secretion by long-lived plasma cells fuels chronic inflammation and disease flares.

Conclusions:

• Long-lived plasma cells are critical for the chronicity of autoimmune diseases.
• Current therapeutic strategies are insufficient for eliminating these persistent cells.
• Targeting long-lived plasma cells represents a promising novel therapeutic avenue for autoimmune diseases.